CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 28, 2021-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the following upcoming investor conferences in May:

• Bank of America Health Care Conference: fireside chat on Tuesday, May 11, 2021 at 10:15 am ET.
• RBC Capital Markets Global Healthcare Conference: fireside chat on Tuesday, May 18, 2021 at 8:35 am ET.

A live webcast of each presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcasts will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005207/en/

Investor
Jeff Boyle, 617-949-4256
Jeff.Boyle@sagerx.com

Media
Maureen L. Suda, 617-949-4289
maureen.suda@sagerx.com

Source: Sage Therapeutics, Inc.